Exagen Stock (NASDAQ: XGN) stock price, news, charts, stock research, profile.
You can purchase shares of Exagen (NASDAQ:XGN) through any online brokerage.
Other companies in Exagen’s space includes: Fortress Biotech (NASDAQ:FBIO), HOOKIPA Pharma (NASDAQ:HOOK), OncoCyte (NASDAQ:OCX), Intensity Therapeutics (NASDAQ:INTS) and CARISMA Therapeutics (NASDAQ:CARM).
Exagen has a consensus price target of $9.00.
The stock price for Exagen (NASDAQ: XGN) is $2.78 last updated October 17, 2024 at 7:42 PM EDT.
There are no upcoming dividends for Exagen.
Exagen’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Exagen.
Exagen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.